SEC Filing Summary: Ra Medical Systems, Inc.
Business Context and Reporting Period
This is a Current Report on Form 8-K filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) on August 24, 2021. The registrant is incorporated in Delaware and trades on the NYSE American under the symbol RMED. The company identifies itself as an emerging growth company.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose a slide presentation intended for the company's investor relations website.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document functions as a regulatory disclosure mechanism for an attached investor presentation (Exhibit 99.1).
Guidance, Outlook, and Risks
Management commentary, guidance, and risk factors are contained within the attached Exhibit 99.1 (Investor Presentation) rather than the body of this 8-K. The filing explicitly states that the information in the presentation is not "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other documents unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name is Ra Medical Systems, Inc., as the input metadata incorrectly listed "Catheter Precision, Inc."
- Access Exhibit 99.1 (Investor Presentation) to review actual financial data, strategic outlook, and management commentary.
- Note that the presentation content is not legally "filed" with the SEC and carries different liability standards than the 8-K itself.
- Confirm the company's status as an emerging growth company for accounting standard compliance.